title: Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers.
abstract: There is controversy concerning the prognosis of breast cancers arising in women carrying loss of function mutations in the breast cancer susceptibility genes BRCA1 and BRCA2. This study was carried out to assess the likely hormone dependence of this group of tumours in comparison with an age and grade matched group of control sporadic tumours. We used quantitative immunohistochemical analysis for the oestrogen receptor (ER), progesterone receptor (PgR), cyclin D1 and pS2 on sections of primary tumours and ductal carcinoma in situ (DCIS). Expression of PgR (P < 0.05) and cyclin D1 (P < 0.01) was low in the BRCA1- and BRCA2-associated cancers compared with sporadic cases. The low frequency of expression of ER (9/40), PgR (2/40) cyclin D1 (5/36) and pS2 (5/36) in the familial tumours indicates that the majority of such tumours will be oestrogen insensitive and unlikely to respond to hormonal manipulation even at the in situ stage in their evolution. The low level of PgR (2/40 cases) suggests that there may be some abnormality of transactivating function of the ER in these tumours.
authors.affiliation: Institute of Cancer Research, Sutton, Surrey, U.K.
authors.forename: P
authors.initials: P
authors.lastname: Osin
authors.forename: B A
authors.initials: BA
authors.lastname: Gusterson
authors.forename: E
authors.initials: E
authors.lastname: Philp
authors.forename: J
authors.initials: J
authors.lastname: Waller
authors.forename: J
authors.initials: J
authors.lastname: Bartek
authors.forename: J
authors.initials: J
authors.lastname: Peto
authors.forename: T
authors.initials: T
authors.lastname: Crook
mesh_terms: D000328:Adult; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism; D018270:Carcinoma, Ductal, Breast / Q000235:genetics* / Q000378:metabolism; D019938:Cyclin D1 / Q000378:metabolism; D005260:Female; D019398:Genes, BRCA1 / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics*; D011506:Proteins / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics*; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins
chemical_list: D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D011506:Proteins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C051838:TFF1 protein, human; D014157:Transcription Factors; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins; D019938:Cyclin D1